Skip to main content
BioSenic SA logo

BioSenic SA — Investor Relations & Filings

Ticker · BIOS ISIN · BE0974280126 LEI · 549300HFIIMTOP1DFR76 BR Professional, scientific and technical activities
Open in API
Filings indexed 968 across all filing types
Latest filing 2022-05-09 AGM Information
Country BE Belgium
Listing BR BIOS

About BioSenic SA

http://www.biosenic.com/

BioSenic SA is a biotechnology company focused on developing innovative treatments for autoimmune diseases, inflammatory conditions, and bone disorders. The company's core activities are centered on two main technology platforms: one based on arsenic trioxide (ATO) for its immunomodulatory properties, and another involving allogeneic cell therapy for tissue repair and regeneration. BioSenic's objective is to address significant unmet medical needs in the fields of regenerative and immune medicine by advancing its clinical assets through development.

Recent filings

Filing Released Lang Actions
BOTHE_PR_2022-05-09_AGM-EGM 2022_FR_vFinal.pdf
AGM Information Classification · 95% confidence The document is titled "COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE" (Press Release - Regulated Information) dated May 9, 2022. The core subject is the announcement that the Annual General Meeting (AGM) will be held on June 8, 2022, and that the preparatory documents are being made available to shareholders. This document is not the AGM presentation itself, nor is it the full set of proxy materials (like DEF 14A or PSI). Instead, it is an announcement about the upcoming meeting and the availability of related documents. This fits best under the category for announcements related to general meetings, specifically the AGM. The most precise code for materials related to the Annual General Meeting is AGM-R, although this document is an announcement *about* the AGM and the availability of its documents. Given the options, AGM-R covers the subject matter (AGM), but RPA (Report Publication Announcement) might also apply if this were purely about publishing documents. However, since the primary focus is the *convocation* and details of the AGM itself, AGM-R is the most relevant classification for the event being announced, even if the document itself is a press release announcing it. If the document were solely about the voting results, DVA would apply. Since it announces the meeting and the availability of materials, AGM-R is the strongest fit among the specific meeting-related codes.
2022-05-09 French
BOTHE_AR2021_EN_vFinal.pdf
Annual Report Classification · 100% confidence The document is explicitly titled 'FINANCIAL REPORT 2021' and contains a comprehensive table of contents covering business overview, corporate governance, remuneration, consolidated financial statements, and statutory accounts for the fiscal year ending 31 December 2021. It is clearly the full annual report of Bone Therapeutics SA, not an announcement or a summary. FY 2021
2022-04-29 English
BOTHE_AR2021_FR_vFinal.pdf
Annual Report Classification · 100% confidence The document is explicitly titled 'RAPPORT FINANCIER 2021' and contains a comprehensive table of contents covering the Board of Directors' report, corporate governance, financial statements (IFRS), notes to the financial statements, and the auditor's report for the fiscal year ending December 31, 2021. This structure is characteristic of a full Annual Report (10-K equivalent). FY 2021
2022-04-29 French
549300HFIIMTOP1DFR76-2021-12-31-en.xhtml
Annual Report Classification · 100% confidence The document is explicitly titled 'FINANCIAL REPORT 2021' and contains comprehensive sections including a letter to shareholders, business overview, financial review, corporate governance, and remuneration reports for the fiscal year ending December 31, 2021. It is a full-length annual report detailing the company's activities and financial performance, fitting the definition of a 10-K (Annual Report). FY 2021
2022-04-29 English
BOTHE_AR2021_EN_549300HFIIMTOP1DFR76.zip
Annual Report (ESEF) Classification · 100% confidence FY 2021
2022-04-29 English
549300HFIIMTOP1DFR76-2021-12-31-fr.xhtml
Annual Report Classification · 100% confidence The document is explicitly titled 'RAPPORT FINANCIER 2021' (Financial Report 2021) for 'BONE THERAPEUTICS SA' and covers the fiscal year ending December 31, 2021. It contains a comprehensive table of contents, a letter to shareholders, a detailed overview of activities, governance information, and references to consolidated accounts. This structure and content align perfectly with the definition of an Annual Report (10-K). FY 2021
2022-04-29 French

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.